NEW YORK, March 29, 2011 /PRNewswire/ -- BlackRock Inc. will replace Genzyme Corp. in the S&P 500 index after the close of trading on Friday, April 1, 2011. S&P Global 1200 constituent Sanofi-aventis is acquiring Genzyme in a deal expected to be completed soon, pending final conditions.
Standard & Poor's will monitor this transaction, and post any relevant updates on its website: www.standardandpoors.com.
BlackRock is a publicly owned investment manager. Headquartered in New York, NY, the company will be added to the S&P 500 GICS (Global Industry Classification Standard) Asset Management & Custody Banks Sub-Industry index.
Following is a summary of the change:
S&P 500 INDEX - April 1, 2011 GICS ECONOMIC GICS SUB- COMPANY SECTOR INDUSTRY Asset Management & Custody ADDED BlackRock Financials Banks DELETED Genzyme Health Care Biotechnology ------- ------- ----------- -------------
For more information about S&P Indices, please visit www.standardandpoors.com/indices.
About S&P Indices
S&P Indices, the world's leading index provider, maintains a wide variety of investable and benchmark indices to meet an array of investor needs. Over $1.25 trillion is directly indexed to Standard & Poor's family of indices, which includes the S&P 500, the world's most followed stock market index, the S&P/Case-Shiller Home Price Indices, the leading measure of U.S. home prices, the S&P Global BMI, an index with approximately 11,000 constituents, the S&P GSCI, the industry's most closely watched commodities index, and the S&P National AMT-Free Municipal Bond Index, the premier investable index for U.S. municipal bonds. For more information, please visit www.standardandpoors.com/indices.
For more information contact:
David M. Blitzer, Ph.D.
Managing Director & Chairman of the Index Committee
(212) 438-3907
Standard & Poor's
Web site: http://www.standardandpoors.com/
